{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}],"title":"Experienced no toxicities"},{"measurements":[{"groupId":"OG000","value":"3"}],"title":"Experienced at least one toxicity"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"}],"units":"Participants"}],"description":"The number of patients experiencing at least one toxicity at the lowest dose of bendamustine. A toxicity is defined as one or more of the following: Upper respiratory infection; anemia; thrombocytopenia; neutropenia; shortness of breath on exertion; decreased appetite; nausea; neuropathy; anxiety; arthritis; and hypercalcemia.","groups":[{"description":"Bendamustine is combined with standard chemotherapy","id":"OG000","title":"Bendamustine"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"No patients were analyzed as study was terminated early after external sponsor withdrew support. Therefore, data necessary for planned analyses were not collected.","reportingStatus":"POSTED","timeFrame":"21 days","title":"Number of Patients Experiencing a Toxicity","type":"PRIMARY","unitOfMeasure":"Participants"}